Nicotine Transdermal System Patch Patch, Extended Release
Product Images NDC 68001-697

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Nicotine Transdermal System Patch (NDC 68001-697). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

14mg 7 Patches (Nicotine Transdermal System Patch 14mg 7 Patches)

This text provides information about nicotine transdermal system patches designed to aid in smoking cessation. The patches deliver 14mg of nicotine over a 24-hour period and are intended for individuals who smoke more than 10 cigarettes per day. The package includes a behavior support program with a self-help guide. The treatment program consists of either 6 weeks for heavy smokers or a 7-patch one-week kit for lighter smokers. For further details or questions, contact the provided customer service number.*

FDA Label Image

14mg 14 Patches (Nicotine Transdermal System Patch 14mg 14 Patches)

This text appears to be a description of a stop smoking aid product. It likely contains information about a nicotine transdermal patch system designed to help individuals quit smoking. The product may include a behavior support program with a self-help guide and details on the dosage and usage instructions for cigarettes smoked per day. For more information or questions, contact the provided customer service number.*

FDA Label Image

21 mg 14 Patches (Nicotine Transdermal System Patch 21mg 14patches)

This is a description of a Nicotine Transdermal System Patch, delivering 21mg of nicotine over 24 hours to aid in quitting smoking. The package includes 14 patches and provides guidance based on the number of cigarettes smoked daily. The product is designed to help individuals gradually reduce their nicotine intake and quit smoking successfully.*

FDA Label Image

21mg 28 Patches (Nicotine Transdermal System Patch 21mg 28patches)

The text is not readable.*

FDA Label Image

21mg 7 Patches (Nicotine Transdermal System Patch 21mg 7 Patches)

This text appears to be a description of a Nicotine Transdermal System Patch used for smoking cessation. It includes details about Step 1 of the program, which delivers 21mg of nicotine over 24 hours. The package contains 7 patches for a 1-week course within the full treatment course that consists of 28 patches. The product also comes with a Behavior Support Program and a self-help guide. This patch is aimed at smokers who smoke more than 10 cigarettes per day.*

FDA Label Image

7mg 14 Patches (Nicotine Transdermal System Patch 7mg 14 Patches)

FDA Label Image

7mg (Nicotine Transdermal System Patch 7mg 7 Patches)

This text appears to be describing a nicotine transdermal system patch, specifically for use as a smoking cessation aid. The patch delivers 7mg of nicotine over a 24-hour period. It mentions using the patch after completing Step 2 of the program and provides information about a behavior support program with a self-help guide. The text suggests that a full treatment course consists of 14 patches over 2 weeks.*

FDA Label Image

Steps (Steps)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.